# MassIVE Data Submission and Reanalysis: A Practical Guide for Proteomics Researchers

MassIVE is the Mass Spectrometry Interactive Virtual Environment, a public proteomics repository operated in the United States and a member of the ProteomeXchange Consortium. Researchers deposit raw mass spectrometry files, peak lists, identification results, and metadata so that datasets receive a unique PXD accession number and become publicly accessible when the associated publication is released. This article explains how to create a MassIVE account, structure a submission, upload files, add metadata, and use MassIVE data for reanalysis. The intended readers are biology students, laboratory professionals, and life-science practitioners who generate proteomics data and need to comply with repository requirements or reuse existing public datasets.

## The Role of MassIVE Within the ProteomeXchange Consortium

MassIVE operates within a unified framework for mass spectrometry-based proteomics repositories. The ProteomeXchange Consortium standardizes how datasets are submitted and shared across member repositories, which include the PRIDE database in the United Kingdom, PeptideAtlas and PASSEL, MassIVE in the United States, and jPOST in Japan. Each member repository enforces common data submission guidelines and metadata requirements so that a dataset deposited in one repository can be discovered and accessed through any other member. The Consortium assigns a unique PXD accession number to every dataset, and that dataset becomes publicly available as soon as the associated scientific publication is released. Researchers can search across all member repositories through the ProteomeCentral portal, which functions as a unified search interface for datasets stored in any ProteomeXchange member [7].

For a researcher preparing to deposit data, the practical consequence is that MassIVE submission follows the same general structure as submission to PRIDE or jPOST. The metadata fields, file organization expectations, and accession workflows are designed to be interoperable. A dataset prepared for MassIVE can be transferred to another member repository if needed, and a dataset deposited elsewhere can be reanalyzed using MassIVE tools. This interoperability matters because journals increasingly require deposition in a ProteomeXchange member repository as a condition of publication, and reviewers may check that the PXD accession is active and that the data can be accessed.

The Consortium's common identifier space means that a dataset receives a PXD accession regardless of which member repository hosts it. This unified approach reduces confusion for readers who encounter accession numbers in publications, because the same format is used across all repositories. The ProteomeCentral portal provides a single entry point for searching datasets across all members, which is particularly useful for researchers who want to find related datasets or compare their own results with published data.

## Creating a MassIVE Account and Preparing for Submission

Before submitting data, a researcher must create an account on the MassIVE website. The account creation process requires a valid email address and basic institutional information. Once the account is active, the researcher can access the submission portal, which is the primary interface for creating datasets, uploading files, and adding metadata. The submission portal is distinct from the search interface, which is used to browse and download existing datasets.

Account preparation should include verifying institutional affiliation and confirming that the researcher has permission to deposit the data. Many institutions have data-sharing policies that require approval before deposition, particularly for human-derived samples or data generated under specific funding agreements. The researcher should check whether the funding agency requires a specific data availability statement or a particular repository. Some funders mandate deposition in a specific ProteomeXchange member, while others accept any member repository.

The submission process also requires the researcher to decide which files constitute the dataset. A typical MassIVE submission includes raw instrument files, peak list files, database search results, protein sequence databases in FASTA format, and a metadata file that describes the experimental design. The researcher should organize these files in a clear directory structure before beginning the upload, because the file organization affects how reviewers and other researchers can navigate the dataset.

Researchers who are new to data organization and file management can benefit from foundational training. The Carpentries lessons provide structured instruction on data organization, shell scripting, and version control that are directly applicable to preparing a repository submission [6]. These skills help researchers maintain consistent file naming, track file versions, and document their analysis workflows in a way that supports reproducible data sharing.

## Structuring a MassIVE Dataset Submission

A MassIVE dataset is organized around a central metadata file that describes the experiment. The metadata file follows a tab-delimited format and includes fields for sample names, experimental conditions, biological replicates, technical replicates, fractionation details, and instrument parameters. The metadata file is the primary mechanism by which other researchers understand what was measured and how the measurements were made.

The metadata file should include the following categories of information:

**Sample information.** Each sample should have a unique name that matches the file names in the raw data directory. The sample description should include the organism, tissue or cell type, treatment conditions, and any relevant biological context. For example, a sample from a drug-treated cell line should specify the drug, concentration, exposure time, and the control condition to which it will be compared.

**Experimental design.** The metadata should indicate which samples are biological replicates, which are technical replicates, and how samples were grouped for statistical analysis. This information is essential for reanalysis because differential expression analysis requires knowledge of the experimental structure. A dataset that lacks replicate information cannot be properly reanalyzed for statistical significance.

**Instrument and acquisition parameters.** The mass spectrometer model, ionization source, acquisition mode, and key instrument settings should be recorded. For data-dependent acquisition, the researcher should specify the number of precursor ions selected per cycle, the dynamic exclusion settings, and the collision energy. For data-independent acquisition, the researcher should specify the isolation window scheme and the spectral library used for analysis.

**Data processing parameters.** The database search engine, search parameters, protein sequence database version, decoy strategy, and false discovery rate thresholds should be documented. This information allows other researchers to reproduce the identification results or to reanalyze the raw data with different parameters.

The metadata file should be validated before submission. MassIVE provides validation tools that check for missing required fields, inconsistent sample names, and file name mismatches. A submission that fails validation cannot be completed, so the researcher should run validation early in the process to identify and correct errors.

A recurring problem in public proteomics datasets is the absence of a standardized sample and data relationship format for proteomics metadata [8]. This means that the structure of metadata tables can vary substantially between datasets, making cross-dataset comparisons difficult. Researchers should follow the ProteomeXchange metadata guidelines as closely as possible and document any deviations in the dataset description.

## Uploading Files to the MassIVE Submission Portal

File upload to MassIVE is performed through the submission portal using either a web-based upload interface or an FTP client. The web-based interface is suitable for smaller datasets, while FTP is recommended for large raw files that can exceed several gigabytes per file. The researcher should ensure that the internet connection is stable and that the upload is not interrupted, because interrupted uploads can corrupt files or leave incomplete datasets.

The file upload process should follow a logical directory structure that mirrors the experimental design. A recommended structure is:

```
dataset_name/
  raw_data/
    sample1.raw
    sample2.raw
  peak_lists/
    sample1.mgf
    sample2.mgf
  search_results/
    combined_results.mzid
  databases/
    reviewed_proteins.fasta
  metadata/
    metadata_table.tsv
```

This structure allows reviewers and reanalysis researchers to locate files quickly. The raw data directory contains the instrument output files, the peak lists directory contains the processed spectra, the search results directory contains the identification output, and the databases directory contains the protein sequence database used for the search.

File naming should be consistent and descriptive. File names should include the sample identifier, the fraction number if applicable, and the acquisition mode. For example, a file name such as `drug_treated_rep1_fraction3.raw` is more informative than `sample7.raw`. Consistent file naming reduces confusion during reanalysis and helps other researchers map files to the metadata table.

Inconsistent file naming has been identified as a systemic barrier to data reuse in public proteomics repositories [8]. When file names do not match the metadata table, reanalysis researchers must spend substantial time reconstructing the sample mapping or may abandon the dataset entirely. The researcher should verify that every file name in the raw data directory appears in the metadata table and that the sample names are consistent across all files.

## Adding Metadata and Completing the Submission

After files are uploaded, the researcher must complete the metadata entry in the submission portal. The portal provides a form that guides the researcher through the required fields, including the dataset title, description, keywords, sample descriptions, and experimental protocol. The title should be descriptive and include the organism, the experimental condition, and the analytical approach. A title such as "Label-free quantitative proteomics of drug-treated HeLa cells" is more useful than "Proteomics dataset."

The dataset description should provide sufficient context for a researcher who is not familiar with the study. The description should include the biological question, the experimental design, the key findings, and any limitations of the data. This description is the first thing that other researchers read when they discover the dataset, so it should be written clearly and completely.

The researcher must also specify the data availability status. MassIVE allows datasets to be kept private until publication, at which point they become publicly accessible. The researcher can provide a reviewer access link that allows journal reviewers to access the data without making it public. This feature is important for manuscripts under review, because reviewers need to verify the data without the dataset being publicly released.

The submission is completed when the metadata is validated and the researcher confirms that all files have been uploaded. The portal then assigns a MassIVE accession number, which is distinct from the ProteomeXchange PXD accession. The PXD accession is assigned when the dataset is registered with the ProteomeXchange Consortium, which occurs automatically for MassIVE submissions.

## Preparing Data for Reanalysis: What Makes a Dataset Reusable

The reusability of a deposited dataset depends on the completeness and transparency of the metadata and the availability of files in open, interoperable formats. A recent analysis of public proteomics datasets identified recurring barriers that prevent effective reanalysis. These barriers include the absence of a standardized sample and data relationship format for proteomics metadata, missing details about decoy sets used for false discovery rate assessment, proprietary-only outputs that cannot be opened in community-standard tools, missing data-independent acquisition spectral libraries or protein sequence database files, absent or vague normalization and statistical parameters, inconsistent file naming, and insufficient biological or technical replication [8].

The practical implication for a researcher preparing a submission is that the dataset should include all files necessary for reanalysis, beyond the raw instrument files. The protein sequence database in FASTA format should be included, because reanalysis requires the same database that was used for the original search. The spectral library for data-independent acquisition should be included, because without it the raw data cannot be reanalyzed with the same approach. The search parameters and statistical analysis parameters should be documented in the metadata, because reanalysis requires knowledge of how the original analysis was performed.

File formats also matter for reusability. Proprietary formats such as Thermo `.msf` files or Progenesis output files cannot be opened by all analysis tools. Open formats such as `.mzML`, `.mzIdentML`, and `.mgf` are preferred because they can be read by a wide range of software. The researcher should include both the proprietary output and the open-format version when possible, so that other researchers can choose the format that works with their analysis pipeline.

The consequences of incomplete metadata and proprietary formats can be substantial. In one analysis of public datasets, reanalysis produced 13,068 proteins compared to 4,923 proteins in the original study, and 108 differentially expressed proteins compared to 11 in the original analysis [8]. These large discrepancies demonstrate that the choice of analysis parameters and the completeness of the deposited information can dramatically affect the conclusions drawn from the same raw data.

## Using MassIVE for Data Reanalysis

MassIVE provides tools for reanalyzing deposited datasets, including the MassIVE Reanalysis interface and the MassIVE Search tool. These tools allow researchers to search raw data against protein sequence databases, to compare their own results with deposited datasets, and to access processed results from previous reanalyses.

The MassIVE Search tool accepts raw data files or peak lists and performs database searching using common search engines. The researcher specifies the protein sequence database, the search parameters, and the false discovery rate threshold. The search results can be viewed online or downloaded for further analysis. This tool is useful for researchers who want to reanalyze a dataset with different search parameters or a different database.

The MassIVE Reanalysis interface provides access to datasets that have been reanalyzed by other researchers. These reanalyses include processed results, such as protein identifications and quantifications, that can be compared with the original results. The reanalysis interface is useful for researchers who want to assess the robustness of published findings or to explore alternative analysis approaches.

For researchers who prefer to perform their own reanalysis using local software, the deposited files can be downloaded and processed with tools such as those available through Bioconductor. The Bioconductor project provides packages for proteomics data analysis, including packages for reading raw data, performing quality control, and conducting differential expression analysis [3]. The Galaxy Training Network provides tutorials for proteomics analysis workflows that can be applied to downloaded datasets [4]. The nf-core documentation describes community pipelines for proteomics analysis that can be run on local or cloud infrastructure [5].

The EMBL-EBI Training program provides learning pathways for bioinformatics data resources, including training on data submission and analysis [2]. These resources are particularly useful for researchers who are new to proteomics data analysis and need structured instruction on how to work with public datasets.

## At a Glance: MassIVE Submission Decision Table

| Decision Point | Recommended Action | Common Error | Consequence of Error |
| --- | --- | --- | --- |
| File format for raw data | Include open formats such as `.mzML` alongside proprietary formats | Submitting only proprietary `.raw` files | Reanalysis tools cannot read the data, limiting reuse |
| Protein sequence database | Include the exact FASTA file used for the search | Omitting the FASTA file or using an unstated version | Reanalysis cannot reproduce identifications |
| Metadata completeness | Document replicates, treatments, and statistical parameters | Providing only sample names without experimental context | Differential expression analysis is impossible |
| Data availability timing | Keep private until publication, provide reviewer link | Releasing data before publication | Competitors can access unpublished findings |
| File naming consistency | Use descriptive names that match metadata table | Using arbitrary names such as `sample1.raw` | Reviewers cannot map files to experimental conditions |

## Practical Steps for Submitting a Dataset to MassIVE

The following steps describe the submission process from account creation to completion. These steps are based on the standard MassIVE submission workflow and the ProteomeXchange submission guidelines.

**Step 1: Create an account and verify access.** Register on the MassIVE website with an institutional email address. Confirm that you have permission to deposit the data and that the funding agency or institution does not require a different repository.

**Step 2: Organize files in a directory structure.** Create directories for raw data, peak lists, search results, databases, and metadata. Rename files so that names are descriptive and consistent with the metadata table.

**Step 3: Prepare the metadata table.** Create a tab-delimited file that describes each sample, the experimental conditions, the replicates, and the acquisition parameters. Include the instrument model, acquisition mode, and search parameters.

**Step 4: Upload files through the submission portal.** Use the web interface for small files or FTP for large raw files. Verify that all files are uploaded completely and that file names match the metadata table.

**Step 5: Complete the metadata entry in the portal.** Enter the dataset title, description, keywords, and sample descriptions. Specify the data availability status and provide a reviewer access link if needed.

**Step 6: Validate and submit.** Run the validation check to identify missing fields or file name mismatches. Correct any errors and submit the dataset. Record the MassIVE accession number and the PXD accession number for use in the manuscript.

**Step 7: Verify public access after publication.** After the associated manuscript is published, confirm that the dataset is publicly accessible and that the PXD accession resolves through the ProteomeCentral portal.

## Records and Measurements for Submission Quality

The quality of a MassIVE submission can be assessed through specific records and measurements that the researcher should track during the submission process.

**File count and total size.** Record the number of files and the total data size. This information is useful for planning the upload and for verifying that all files were transferred completely.

**Metadata validation results.** Record the output of the validation check, including any warnings or errors. A clean validation result indicates that the metadata is complete and consistent.

**Upload completion time.** Record the time required for the upload. Large datasets can require several hours, so the researcher should plan accordingly and ensure that the connection is stable.

**Accession numbers.** Record the MassIVE accession and the PXD accession. These numbers are used in the manuscript and in the data availability statement.

**Reviewer access link.** Record the reviewer access link and the date on which it was generated. The link should be included in the manuscript submission materials.

**Public access verification date.** After publication, verify that the dataset is publicly accessible and record the verification date. This verification is important because some journals check that the data is accessible before final acceptance.

## Common Failure Patterns in MassIVE Submissions

Several recurring problems reduce the usability of deposited datasets. Recognizing these patterns can help researchers avoid them in their own submissions.

**Incomplete metadata.** The most common failure is incomplete metadata. Datasets that lack information about replicates, treatments, or statistical parameters cannot be reanalyzed for differential expression. The metadata table should be reviewed by a colleague who is not involved in the study to ensure that all necessary information is present.

**Missing protein sequence databases.** Many datasets omit the FASTA file used for the database search. Without this file, reanalysis cannot reproduce the original identifications. The FASTA file should be included in the submission, and the version and download date should be recorded in the metadata.

**Proprietary-only outputs.** Datasets that include only proprietary output formats cannot be opened by all analysis tools. The researcher should include open-format versions of the results, such as `.mzIdentML` or `.mzML`, to maximize reusability.

**Inconsistent file naming.** File names that do not match the metadata table create confusion during reanalysis. The researcher should verify that every file name in the raw data directory appears in the metadata table and that the sample names are consistent.

**Insufficient replication.** Datasets with insufficient biological or technical replication cannot support statistical analysis. The researcher should ensure that the experimental design includes adequate replication before deposition, because this cannot be corrected after the data is generated.

**Vague normalization and statistical parameters.** The metadata should specify the normalization method, the imputation approach, and the statistical test used for differential expression. Without this information, other researchers cannot reproduce the analysis or assess its validity.

**Missing decoy set documentation.** The decoy strategy used for false discovery rate assessment should be documented in the metadata. Without this information, reanalysis researchers cannot verify the quality of the identifications or compare the false discovery rate across datasets [8].

## Limitations of MassIVE Submission and Reanalysis

MassIVE submission and reanalysis have limitations that researchers should understand before relying on the repository for data sharing or reuse.

**Metadata format limitations.** MassIVE does not enforce a standardized sample and data relationship format for proteomics metadata. This means that the metadata structure can vary between datasets, making cross-dataset comparisons difficult. The researcher should follow the ProteomeXchange metadata guidelines as closely as possible to minimize this limitation.

**File format compatibility.** Not all analysis tools can read all file formats. Proprietary formats from instrument vendors may not be readable by open-source tools, and open formats may not preserve all instrument-specific information. The researcher should include multiple formats when possible to maximize compatibility.

**Reanalysis discrepancies.** Reanalysis of deposited data can produce results that differ from the original analysis. Differences in search parameters, database versions, normalization methods, and statistical approaches can lead to different protein identifications and different lists of differentially expressed proteins. These discrepancies do not necessarily indicate that the original analysis was wrong, but they do highlight the importance of transparent metadata and executable analysis provenance [8].

**Data quality depends on the original experiment.** The quality of a reanalysis depends on the quality of the original data. Datasets with insufficient replication, poor sample preparation, or inadequate quality control cannot be rescued by reanalysis. The researcher should assess data quality before depositing and should document any known limitations in the dataset description.

**Repository policies may change.** Repository policies, file format requirements, and metadata standards can change over time. The researcher should check the current MassIVE documentation before submission and should be prepared to adapt to updated requirements.

**Detection bias in mixed samples.** For experiments involving mixed samples of different organisms, the relative abundance of proteins from each organism can affect detection. In a cross-kingdom symbiosis study, the detection of bacterial proteins decreased by 50% in coculture compared to monoculture due to the abundance of algal proteins [10]. This detection bias can lead to false-positive reports of downregulated proteins. Researchers should be aware of this limitation when designing experiments and interpreting reanalysis results from mixed-species datasets.

## Quality Controls for Submission and Reanalysis

Quality control should be applied at multiple stages of the submission and reanalysis process.

**Before submission.** Verify that the raw data files are complete and that the instrument acquisition was successful. Check that the search results are consistent with the raw data and that the protein identifications meet the false discovery rate threshold. Review the metadata table for completeness and consistency.

**During submission.** Run the validation check and correct any errors. Verify that all files were uploaded completely by comparing the file count and total size with the local copies. Confirm that the accession numbers are recorded correctly.

**After submission.** Download a sample of the deposited files and verify that they can be opened and processed. Confirm that the metadata table matches the file names and that the dataset description is accurate. After publication, verify that the dataset is publicly accessible.

**During reanalysis.** When reanalyzing a deposited dataset, assess the data quality before performing statistical analysis. Check the number of replicates, the quality of the raw data, and the completeness of the metadata. If the metadata is insufficient for the intended analysis, document the limitation and consider whether the analysis is feasible.

**Normalization and statistical validation.** When performing differential expression analysis, the researcher should document the normalization method, the imputation approach, and the statistical test used. These parameters should be reported in any publication that describes the reanalysis results, because they affect the interpretation of the findings.

## Professional Escalation Criteria for Submission Problems

Some submission problems require escalation to institutional or repository support. The researcher should seek professional assistance in the following situations.

**Persistent validation errors.** If the validation check continues to report errors after multiple attempts to correct them, the researcher should contact MassIVE support. The support team can identify the cause of the errors and provide guidance on how to resolve them.

**Upload failures.** If the upload repeatedly fails or if files are corrupted during transfer, the researcher should contact the institutional IT support and MassIVE support. Large datasets may require specialized transfer methods or a more stable network connection.

**Metadata requirements that conflict with institutional policy.** If the metadata requirements conflict with institutional data-sharing policies or with the consent agreements for human-derived samples, the researcher should consult the institutional data governance office before proceeding.

**Discrepancies between original and reanalysis results.** If a reanalysis produces results that differ substantially from the original analysis, the researcher should consult a bioinformatics specialist or a statistician. The discrepancy may indicate an error in the original analysis, a problem with the reanalysis approach, or a limitation of the data.

**Data access problems after publication.** If the dataset is not publicly accessible after publication, or if the PXD accession does not resolve through the ProteomeCentral portal, the researcher should contact MassIVE support immediately. This problem can delay or prevent publication if the journal verifies data accessibility.

## Safety and Regulatory Context for Data Submission

Data submission to MassIVE must comply with applicable regulations and institutional policies. The researcher should be aware of the following considerations.

**Human-derived data.** Datasets that include human-derived samples may be subject to privacy regulations and consent requirements. The researcher should ensure that the data does not include identifiable information and that the consent agreements permit public data sharing. De-identified data may still be subject to restrictions, so the researcher should consult the institutional review board or data governance office before submission.

**Controlled access data.** Some datasets may require controlled access instead of public access. MassIVE and other ProteomeXchange members provide mechanisms for controlled access, but the researcher should verify that the repository supports the required access model before submission.

**Export controls.** Some data may be subject to export control regulations, particularly if the data is derived from controlled technologies or if the researcher is subject to specific restrictions. The researcher should consult the institutional export control office if there is any question about whether the data is subject to export controls.

**Funding agency requirements.** Funding agencies may have specific data-sharing requirements, including the repository that must be used, the timeline for deposition, and the format of the data. The researcher should review the funding agreement and the agency data-sharing policy before submission.

**International data sharing.** Data sharing across national boundaries may be subject to additional regulations. The Korea MetAbolomics data rePository (KMAP) provides an example of a national repository that aligns with international standards for quality control and interoperability while serving nationally coordinated data collection [9]. Researchers who deposit data in MassIVE should be aware that the data will be accessible globally and should ensure that their data sharing agreements permit international access.

## Training Resources for MassIVE Submission and Reanalysis

Researchers who are new to proteomics data submission or reanalysis can benefit from structured training resources. The EMBL-EBI Training program provides learning pathways for bioinformatics data resources, including training on data submission and analysis [2]. The Galaxy Training Network offers tutorials for proteomics analysis workflows that can be applied to public datasets [4]. The nf-core documentation describes community pipelines for proteomics analysis that follow reproducibility standards [5]. The Carpentries lessons provide foundational training in computing, data organization, and version control that are useful for managing analysis workflows [6].

The Bioconductor project provides documentation and workflows for proteomics data analysis using the R programming language [3]. Packages such as `rpx`, `mzR`, `QFeatures`, and `DEP` can be used to read public datasets, perform quality control, and conduct differential expression analysis. The Bioconductor documentation includes worked examples that demonstrate how to apply these packages to public data.

Researchers should also consult the NCBI Data Resources for information about related databases and search systems [1]. While MassIVE is operated by the University of California San Diego, the NCBI provides access to related sequence and expression resources that can be used in conjunction with proteomics data.

## Reproducibility Considerations for Reanalysis Workflows

Reproducibility in mass spectrometry-based proteomics depends on transparent metadata, open formats, and executable analysis provenance [8]. Researchers who reanalyze public datasets should document their analysis workflow in sufficient detail that other researchers can reproduce the reanalysis. This documentation should include the software versions, the parameter settings, and the input files used for each step of the analysis.

**Software version tracking.** Record the version numbers of all software packages used in the analysis. Version differences can affect the results, so the exact versions should be documented in the analysis report.

**Parameter documentation.** Record all search parameters, normalization settings, imputation methods, and statistical thresholds used in the analysis. These parameters should be reported in any publication that describes the reanalysis results.

**Input file provenance.** Document the source of all input files, including the PXD accession number, the file names, and the download date. This information allows other researchers to verify that they are using the same input data.

**Workflow execution.** Use workflow management tools or scripting to ensure that the analysis steps are executed in a consistent order. The nf-core documentation describes community pipelines that follow reproducibility standards and can be run on local or cloud infrastructure [5].

**Containerization.** Consider using containerized analysis environments to ensure that the software dependencies are consistent across different computing platforms. Containerization reduces the risk of version conflicts and improves the reproducibility of the analysis.

## Data Interpretation Limits in Reanalysis

Reanalysis of public proteomics data has inherent limitations that researchers should understand before drawing conclusions from the results.

**Detection limits.** The detection of proteins in mass spectrometry experiments depends on the abundance of the proteins in the sample and the dynamic range of the instrument. Lowly abundant proteins may not be detected in some samples, which can affect the interpretation of differential expression results.

**Normalization effects.** The choice of normalization method can substantially affect the results of differential expression analysis. Different normalization methods can lead to different lists of differentially expressed proteins, particularly when the total protein abundance differs between samples.

**Missing value imputation.** The method used to impute missing values can affect the statistical analysis. Some imputation methods assume that missing values are below the detection limit, while others assume that they are randomly missing. The choice of imputation method should be documented and justified.

**Statistical power.** The statistical power of a reanalysis depends on the number of biological replicates in the original experiment. Datasets with insufficient replication cannot support reliable statistical conclusions, regardless of the analysis approach used.

**Biological interpretation.** The biological interpretation of reanalysis results should be cautious, because the original experimental design may not have been optimized for the specific question being asked in the reanalysis. The researcher should consider whether the original experimental design supports the conclusions drawn from the reanalysis.

## Frequently Asked Questions

### What is the difference between a MassIVE accession and a PXD accession?

A MassIVE accession is assigned by the MassIVE repository when a dataset is submitted. A PXD accession is assigned by the ProteomeXchange Consortium and is the standard identifier used across all member repositories. The PXD accession is the identifier that should be cited in publications and used to search for datasets through the ProteomeCentral portal [7].

### How long does a MassIVE submission take?

The time required depends on the dataset size and the upload method. Small datasets can be submitted in under an hour, while large datasets with many raw files can require several hours for the upload alone. The metadata preparation and validation can add additional time, so researchers should plan for at least half a day for a typical submission.

### Can I keep my dataset private until my paper is published?

Yes. MassIVE allows datasets to be kept private until the associated publication is released. The researcher can generate a reviewer access link that allows journal reviewers to access the data without making it public. The dataset becomes publicly accessible when the researcher releases it or when the publication is confirmed.

### What files must I include in a MassIVE submission?

A complete submission includes raw instrument files, peak lists, search results, the protein sequence database in FASTA format, and a metadata table. The researcher should also include spectral libraries for data-independent acquisition experiments and open-format versions of the results when possible. The protein sequence database and spectral library are essential for reanalysis, because without them the raw data cannot be reanalyzed with the same approach [8].

### Why does my reanalysis produce different results from the original study?

Reanalysis can produce different results because of differences in search parameters, database versions, normalization methods, and statistical approaches. These differences are expected and do not necessarily indicate an error. The original study should document the analysis parameters so that other researchers can understand the source of the differences. Large discrepancies in the number of identified proteins or differentially expressed proteins can occur when the deposited metadata is incomplete or when different analysis workflows are used [8].

### How do I cite a MassIVE dataset in my publication?

The dataset should be cited using the PXD accession number and the MassIVE repository name. The citation should include the accession number, the repository, and the date of access. The data availability statement should describe where the data is deposited and how it can be accessed.

### Can I reanalyze data from other ProteomeXchange members using MassIVE tools?

Yes. MassIVE tools can be used to reanalyze data from any ProteomeXchange member repository, because all members use the same PXD accession system and the same general data structure [7]. The researcher can download data from PRIDE or jPOST and analyze it using MassIVE Search or local tools.

### What should I do if my dataset fails validation?

If the validation check reports errors, the researcher should review the error messages and correct the identified problems. Common errors include missing required metadata fields, file name mismatches, and incomplete file uploads. If the errors persist after correction, the researcher should contact MassIVE support for assistance.

## Related Bioinformatics Guides

- [Olink Proteomics: A Practical Guide to Panel Selection and Data Interpretation](/knowledge/bioinformatics/olink-proteomics-a-practical-guide-to-panel-selection-and-data-interpretation)
- [Proteomics Data Analysis in R: A Practical Workflow for Differential Expression and Visualization](/knowledge/bioinformatics/proteomics-data-analysis-in-r-a-practical-workflow-for-differential-expression-and-visualization)
- [Multi-Omics Integration: A Practical Workflow for Combining Proteomics, Metabolomics, and Epigenomics Data](/knowledge/bioinformatics/multi-omics-integration-a-practical-workflow-for-combining-proteomics-metabolomics-and-epigenomi)
- [Metabolomics Data Analysis in R: A Practical Workflow](/knowledge/bioinformatics/metabolomics-data-analysis-in-r-a-practical-workflow)
- [Microbiome Data Analysis in R: A Practical Guide for Compositional Data](/knowledge/bioinformatics/microbiome-data-analysis-in-r-a-practical-guide-for-compositional-data)

## References and Further Reading

- [NCBI Data Resources](https://www.ncbi.nlm.nih.gov/). National Center for Biotechnology Information.
- [EMBL-EBI Training](https://www.ebi.ac.uk/training). European Bioinformatics Institute.
- [Bioconductor](https://bioconductor.org/). Bioconductor Project.
- [Galaxy Training Network](https://training.galaxyproject.org/). Galaxy Project.
- [nf-core Documentation](https://nf-co.re/docs). nf-core.
- [The Carpentries Lessons](https://carpentries.org/lessons). The Carpentries.
- [Using the PRIDE Database and ProteomeXchange for Submitting and Accessing Public Proteomics Datasets.](https://pubmed.ncbi.nlm.nih.gov/28902400). Current protocols in bioinformatics, 2017.
- [Preventing Proteomics Data Tombs Through Collective Responsibility and Community Engagement.](https://doi.org/10.1038/s41597-026-06614-8). 2026.
- [Introducing Korea metabolomics data repository (KMAP): bridging Korean metabolomics data to global data sharing infrastructure.](https://doi.org/10.1007/s11306-025-02285-5). 2025.
- [Mono-mix strategy enables comparative proteomics of a cross-kingdom microbial symbiosis.](https://doi.org/10.1371/journal.pone.0340253). 2026.
- [Integrated biotechnological and artificial intelligence innovations for plant improvement.](https://doi.org/10.3389/fpls.2025.1736707). 2025.

> This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.